Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study

Liver Transplantation

Volumn 14, Issue 10, 2008, Pages 1461-1465

  Spier, Bret J ^a   Pfau, Patrick R ^a   Lorenze, Katelin R ^a   Knechtle, Stuart J ^a   Said, Adnan ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLOSPORIN; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE DUCT DISEASE; BILE DUCT STONE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; GALLSTONE FORMATION; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; INCIDENCE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; STONE FORMATION; SURGICAL RISK; TRIACYLGLYCEROL BLOOD LEVEL;

CASE-CONTROL STUDIES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; GALLSTONES; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 57849138495     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21511     Document Type: Article

References (32)

1. Sheng R, Ramirez CB, Zajko AB, Campbell WL. Biliary stones and sludge in liver transplant patients: a 13-year experience. Radiology 1996;198:243-247.
2. Tsujino T, Isayama H, Sugawara Y, Sasaki T, Kogure H, Nakai Y, et al. Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol 2006;10:2230-2236.
3. Rerknimitr R, Sherman S, Fogel EL, Kalayci C, Lumeng L, Chalasani N, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc 2002;55:224-231.
4. Koivusalo A, Isoniemi H, Salmela K, Edgren J, von Numers H, Hockerstedt K. Biliary complications in one hundred adult liver transplantations. Scand J Gastroenterol 1996; 31:506-511.
5. Maheshwari A, Maley W, Li Z, Thuluvath PJ. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl 2007;12:1645-1653.
6. Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology 1994;191:735-740.
7. Cao S, Cox K, So SS, Berquist W, Lee SP, Haigh WG, et al. Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. Dig Dis Sci 1997;42:1409-1415.
8. Halpern Z, Dudley MA, Lynn MP, Nader JM, Breuer AC, Holzbach RT. Vesicle aggregation In model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase. J Lipid Res 1986;27: 295-306.
9. Phillips RS, Barkin JS. Oral dissolution therapy for cholelithiasis: mix and match. Am J Gastroenterol 1990;85: 1532-1533.
10. Björkhem I, Miettinen T, Reihnér E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987;28:1137-1143.
11. Kempen HJ, Glatz JF, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988;28:1149-1155.
12. Kajiyama G, Fujiyama M, Takata K, Miyoshi A. Serum lipids and lipoproteins In patients with gallstone (relationship between serum lipids and types of stones in roentgenograms and sectional views). Gastmenterol Jpn 1981; 16:553-562.
13. Holzbach RT, Marsh M, Olszewski M, Holan K. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 1973;52:1467-1479.
14. Ko CW, Lee SP. Gallstone formation. Local factors. Gastroenterol Clin North Am 1999;28:99-115.
15. Xu HS, Pilcher JA, Jones RS. Physiologic study of bile salt and lipid secretion In rats after liver transplantation. Ann Surg 1993;217:404-412.
16. Heaton KW, Emmett PM, Symes CL, Braddon FE. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 1993;341:8-10.
17. Rosmorduc, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003;125:452-459.
18. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 2005;242:724-731.
19. Somberg KA, Osorio RW, Lake JR, Roberts JP, Ascher NL. Choledocholithiasis following orthotopic liver transplantation: clinical features, risk factors and endoscopic management [abstract). Gastrointest Endosc 1993;39:328.
20. Ostroff JW. Post-transplant biliary problems. Endoscopic issues in liver transplantation. Gastrointest Endosc Clin North Am 2001;11:163-183.
21. Farouk M, Branum GD, Waiters CR, Cucchiaro G, Helms M, McCann R, et al. Bile compositional changes and cholesterol stone formation following orthotopic liver transplantation. Transplantation 1991;52:727-730.
22. Starzl TE, Putnam CW, Hansbrough JF, Porter KA, Reid HA. Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery 1977;81:212-221.
23. Said A, Safdar N, Lucey MR, Knechtle SJ, D'Alessandro A. Musat A, et al. Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant 2004;4:574-582.
24. Soderdahl G, Nowak G, Duraj F, Wang FH, Einarsson C, Ericzon BG. Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation. Transpl Int 1998; 11 (suppl 1):S231-S238.
25. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002;36:525-531.
26. Hillaire S, Boucher E, Calmus Y, Gane P, Ballet F, Franco D, et al. Effects of bile acids and cholestasts on major histocompatibility complex class I in human and rat hepatocytes. Gastroenterology 1994;107:781-788.
27. Yamazaki K, Suzuki K, Nakamura A, Sato S, Lindor KD, Batts KP, et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 1999;30:71-78.
28. Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med 1995;122:899-905.
29. Huibregtse K. Complications of endoscopic sphincterotomy and their prevention. N Eng] J Med 1996;335:961-963.
30. Brugge WR, Van Dam J. Pancreatic and biliary endoscopy. N Engl J Med 1999;341:1808-1816.
31. Pfau PR, Kochman ML, Lewis JD, Long WB, Lucey MR, Olthoff K, et al. Endoscopic management of postoperative billary complications in orthotopic liver transplantation. Gastrointest Endosc 2000;52:55-63.
32. Bourgeois N, Deviere J, Yeaton P. Bourgeois F, Adler M, Van De Stadt J, et al. Diagnostic and therapeutic endoscopic retrograde cholangiography after liver transplantation. Gastrointest Endosc 1995;42:527-533.